Table 3.
The concentration of biomarkers compared to the control group of healthy people.
| Biomarkers | Patients Group (n = 123) | Control Group (n = 35) | p-Value |
|---|---|---|---|
| CG (0) Median [Q1, Q3] [U/mL] | 222.02 [171.09, 283.47] (n = 81) | 144.18 [93.49, 191.69] (n = 22) | <0.001 |
| CG (1) Median [Q1, Q3] [U/mL] | 355.56 [224.98, 437.38] (n = 37) | 144.18 [93.49, 191.69] (n = 22) | <0.001 |
| CG (2) Median [Q1, Q3] [U/mL] | 195.08 [124.21, 242.01] (n = 34) | 144.18 [93.49, 191.69] (n = 22) | 0.032 |
| MEL (0) Median [Q1, Q3] [pg/mL] | 6.41 [4.26, 8.64] (n = 77) | 37.85 [21.46, 103.82] (n = 23) | <0.001 |
| MEL (1) Median [Q1, Q3] [pg/mL] | 9.34 [5.49, 25.42] (n = 44) | 37.85 [21.46, 103.82] (n = 23) | <0.001 |
| MEL (2) Median [Q1, Q3] [pg/mL] | 9.61 [6.04, 15.53] (n = 31) | 37.85 [21.46, 103.82] (n = 23) | <0.001 |